KRTL Holding Announces Acquisition of Neurogen Brain Balancing, LLC – A Strategic Merger Accelerating Global Neurotech and Mental Wellness Expansion
Lakewood, CO, April 09, 2025 (GLOBE NEWSWIRE) -- FOR IMMEDIATE RELEASE
KRTL Holding Announces Acquisition of Neurogen Brain Balancing, LLC – A Strategic Merger Accelerating Global Neurotech and Mental Wellness Expansion
KRTL Holding Group Inc., a diversified international enterprise focused on biotech innovation, regulatory infrastructure, and strategic investment, is pleased to announce the acquisition of Neurogen Brain Balancing, LLC, a California-based neurotechnology company known for its advanced brain balancing therapies and personalized cognitive optimization systems. This transformative acquisition expands KRTL's presence in the mental wellness space and enhances its position at the intersection of neuroscience, biotechnology, and global healthcare.
This acquisition establishes Neurogen as a subsidiary of KRTL Holding Group Inc., representing a pivotal step in the company's broader strategy to integrate advanced neurotechnology into its ecosystem and support the growth of scalable mental health solutions.
Under the terms of the transaction, KRTL has acquired 100% of Neurogen's equity through a stock-based structure that also includes a collaborative profit-sharing agreement. Additional elements of the consideration include KRTL's commitment to support Neurogen's entry into new markets and provide FDA-related services to enhance regulatory pathways and strategic growth alignment between the two companies.
'We are thrilled to welcome Neurogen into the KRTL Holding Group family,' said Cesar Herrera, CEO of KRTL Holding Group. 'In today's rapidly evolving global environment, diversification is not just a strategy—it's a necessity. By bringing Neurogen into our ecosystem, we strengthen our ability to remain agile, resilient, and forward-thinking across multiple sectors. Their innovative work is a natural fit for our mission to invest in businesses that shape the future.'
Neurogen's proprietary neurotechnology utilizes advanced neuromodulation protocols that support applications ranging from cognitive performance enhancement to stress reduction and post-trauma recovery. The platform is particularly well-positioned to address critical gaps in the continuation of care for patients seeking alternative therapies. By offering non-opioid, non-invasive treatment options with simplified access, the technology aligns with broader healthcare priorities around expanding safe, effective, and accessible behavioral and neurological health interventions.
"This acquisition marks an exciting new chapter for Neurogen. Joining forces with KRTL Holding Group enables us to accelerate our mission of transforming mental health treatment through cutting-edge neurotechnology. With KRTL's global infrastructure and regulatory expertise, we're well-positioned to scale our solutions and reach underserved communities worldwide. Together, we aim to expand access to non-invasive, personalized brain health therapies—advancing a new global standard for neurological wellness," said Gregory Gillispie, President of NeuroGen. "The guidance and infrastructure offered by KRTL enhance our ability to grow responsibly while continuing to focus on improving lives through brain balance."
Strategic Integration and Global Expansion Framework
As part of the integration, Neurogen is being incorporated into KRTL's operational and regulatory infrastructure. These efforts, which include brand alignment across digital channels and investor communications, financial system harmonization, and scalable operational planning, are underway and being informed by both internal leadership and third-party advisors.
KRTL's internal systems, including its Quality Management System (QMS) and Enterprise Resource Planning (ERP) infrastructure, are currently under expert review. This assessment is aimed at identifying the most effective enhancements to support joint business capabilities and long-term performance.
Further coordination is focused on regulatory and clinical alignment, including FDA-compliant trial design and support for international submissions. Neurogen is also positioned to participate in real-world data research through its connection with Centro de Investigaciones Químicas - CIQ S.R.L in Bolivia, contributing to global product validation efforts.
As the collaboration evolves, KRTL intends to issue follow-up announcements that will provide added clarity, updates on integration progress, and forward-looking insights.
About KRTL Holding Group Inc.
KRTL Holding Group Inc. is a dynamic holding company operating through its wholly owned subsidiaries, KRTL Biotech, Inc. and KRTL International Corp. These subsidiaries specialize in biopharmaceutical innovation, international trade, and compliance-driven healthcare advancements. By leveraging strategic mergers, acquisitions, and joint ventures, KRTL Holding Group continues to push the boundaries of scientific research, regulatory compliance, and global business solutions.
Additional information on KRTL is available online at www.krtlholding.com and www.krtl-icc.com and www.krtlbiotech.com.
This press release contains forward-looking statements under the meaning of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, anticipated business developments, regulatory advancements, and strategic growth plans. Such forward-looking statements involve known and unknown risks that may cause actual results to differ materially from those expressed or implied.
KRTL Holding Group assumes no obligation to update or revise forward-looking statements, except as required by law. Any updates will be made in accordance with applicable SEC regulations and disclosure obligations. Readers are cautioned not to place undue reliance on forward-looking statements.
CONTACT: www.krtlholding.com info@krtlholding.com www.krtlbiotech.com info@krtlbiotech.com www.krtl-icc.com info@krtl-icc.comSign in to access your portfolio
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
SOLVE FSHD and Modalis Announce Strategic Collaboration to Develop an Innovative CRISPR-Based Epigenome Editing Treatment for Facioscapulohumeral Muscular Dystrophy
VANCOUVER, British Columbia & TOKYO & WALTHAM, Mass., June 08, 2025--(BUSINESS WIRE)--SOLVE FSHD, a venture philanthropy organization dedicated to accelerating treatments for facioscapulohumeral muscular dystrophy (FSHD), and Modalis Therapeutics Corporation (TSE 4883; "Modalis"), a CRISPR-based epigenome editing therapeutics company focused on rare genetic diseases, today announced a strategic collaboration to develop an innovative therapy for FSHD, a debilitating muscular disorder affecting approximately 1 million individuals worldwide. The novel therapy leverages Modalis's proprietary CRISPR-GNDM® (Guide Nucleotide-Directed Modulation) technology, which can dynamically modulate gene expression without introducing double-strand DNA breaks. SOLVE FSHD will provide strategic funding to support the development of Modalis's MDL-103 program. MDL-103 is an innovative therapeutic solution that continuously suppresses the expression of the DUX4 gene, the toxic disease-causing gene for FSHD, which becomes abnormally activated due to epigenetic changes in the D4Z4 repeat region on chromosome 4. MDL-103 is designed to have durable activity over long periods of time under the control of a strong, muscle-specific promoter, and is delivered to the muscles of patients using a muscle-tropic AAV delivery system. Modalis's CRISPR-GNDM® technology has the potential to transform the treatment of FSHD by epigenetically silencing the expression of DUX4. "SOLVE FSHD is pleased to partner with Modalis and to add them to our diverse portfolio of collaborators that are advancing potential therapies for FSHD," stated Eva Chin, Executive Director of SOLVE FSHD. "SOLVE FSHD identified Modalis as a company committed to finding a cure for this debilitating condition. We were impressed by their unique approach to targeting the epigenetic cause of FSHD, using a platform technology that has shown promise in other neuromuscular diseases. We believe that the support from SOLVE FSHD will allow Modalis to accelerate the advancement of MDL-103 into clinical trials." "We are delighted to be working in partnership with SOLVE FSHD and greatly appreciate the invaluable support for the development of MDL-103," said Haru Morita, CEO of Modalis. "This strategic collaboration is a strong validation of Modalis's CRISPR-GNDM® technology and our MDL-103 program. As a pioneer in this technology, we have demonstrated promising long-term drug efficacy in mouse models, shown durable target engagement and safety in non-human primates, and exhibited excellent biodistribution in neuromuscular disorders. We believe that MDL-103, which incorporates CRISPR-GNDM® technology with a muscle tropic AAV delivery system, has significant potential as a breakthrough treatment for FSHD." About SOLVE FSHD SOLVE FSHD is a venture philanthropic organization established to catalyze innovation and accelerate key research in finding a cure for FSHD. Established by renowned Canadian entrepreneur and philanthropist, Chip Wilson, the Wilson family has committed $100 million to kick-start funding into projects that support the organizations' mission to solve FSHD by 2027. The goal of SOLVE FSHD is to find a solution that can slow down or stop muscle degeneration, increase muscle regeneration and strength, and improve the quality of life for those living with FSHD, visit About Modalis Therapeutics Corporation Modalis was founded in 2016 and conducts research and development activities in Massachusetts, USA. Modalis is a pioneering leader in the field of epigenetic medicine. Modalis develops therapeutics for patients suffering from serious genetic disorders such as neuromuscular diseases, CNS diseases, and cardiomyopathies. Modalis's proprietary CRISPR-GNDM® technology is capable of specifically up or down modulating the expression of disease-relevant genes without introducing double-strand DNA breaks. For more information, visit View source version on Contacts SOLVE FSHDAlexandra Grant, House of Wilsonalexandrag@ Modalis Therapeutics CorporationCorporate Planning Departmentmedia@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 hours ago
- Yahoo
Vanishing immigration is the ‘real story' for the economy and a bigger supply shock than tariffs, analyst says
Protests over ICE raids in the Los Angeles area this weekend highlight the crackdown on undocumented workers at businesses and the overall impact of immigration, legal or otherwise, on the economy. The collapse in immigration represents a bigger negative supply shock than President Donald Trump's tariffs do, Deutsche Bank said. President Donald Trump's mobilization of California National Guard troops to protect immigration officers from protesters highlights his crackdown on undocumented workers and the economic impact of a sudden drop in labor supply. Protests in Los Angeles began on Friday, when armed federal agents clad in camouflage uniforms, tactical vests, and helmets arrived in armored vehicles to carry out a raid on a clothing wholesaler. It was the latest in a series of similar high-profile operations at businesses around the country. Also on Friday, the Labor Department issued its monthly jobs report, which showed the U.S. workforce shrank in May as the number of foreign-born workers saw the biggest back-to-back declines since 2020. That comes after a surge in immigration during the Biden administration helped boost economic activity. According to a Deutsche Bank analysis of data from U.S. Customs and Border Patrol, the number of encounters at the Southwest border has plunged to 12,000 people per month since Trump's inauguration from an average of 200,000 during the year-and-a-half period between January 2022 and June 2024. 'While everyone is focused on the impact of tariffs, the real story for the US economy is the collapse in immigration: down more than 90% compared to the run rate of previous years, equivalent to a slowing in labour force growth of more than 2 million people,' George Saravelos, head of FX research at Deutsche Bank, wrote in a note on Friday. 'This represents a far more sustained negative supply shock for the economy than tariffs.' While Trump has pointed to weaker payroll growth as reasons for the Federal Reserve to cut interest rates, his immigration crackdown gives the central bank, which is already wary of the inflationary effect of his tariffs, another reason to wait and see. That's because a workforce that is growing more slowly doesn't need as much hiring to absorb the additional labor supply. In fact, even as average payroll gains have cooled to 124,000 a month this year from 250,000 in 2024, the jobless rate has hovered around 4.2% since last summer. Wall Street sees a lower breakeven rate for job growth, or the amount of hiring need to keep the unemployment rate steady. By the end of this year, that pace should fall to 90,000 per month from 170,000 now and 210,000 last year, according to Morgan Stanley, which cited deportations and slower immigration. Deutsche Bank warned the collapse of immigration will have broader implications in financial markets, including on the dollar, which has already been battered by Trump's aggressive tariff campaign. 'Last year we were writing that the US was benefitting from a goldilocks mix of high employment growth and low wages precisely because of high immigration numbers,' Saravelos said. 'If recent immigration trends continue, it must follow that over the course of the year the reverse will happen. As the 2022 energy shock showed, a negative supply shock is not good news for a currency.' This story was originally featured on Sign in to access your portfolio
Yahoo
2 hours ago
- Yahoo
Got 'Clutter' In Your Backyard Or A Drained Pool? Insurance Companies Are Using Aerial Images To Decide If You'll Keep Your Coverage
Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. California and Texas homeowners are finding out the hard way that what's visible from the sky could result in losing their home insurance. More insurance companies are using aerial images and footage from satellites and drones to decide whether to renew a policy, and it has nothing to do with wildfire zones. In California, KGO-TV reported in 2023 that long-time AAA customers are being dropped for reasons like backyard clutter, old roofs or even empty swimming pools. In one case, CJ Sveen of Oakley said AAA told him his policy wouldn't be renewed because of 'debris and hazards' in his yard. Don't Miss: Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing — Invest Where It Hurts — And Help Millions Heal: 'Apparently, they have some pictures and they noticed clutter,' Sveen told KGO-TV. 'I find that offensive. How dare you judge me because of my stuff!' Sveen said he had no chance to fix the issue. 'There was no chance to mitigate, clean up, do anything, it was just, you're fired.' Another homeowner, George Nadeau of San Rafael got dropped because AAA said his roof had 'exceeded its useful life.' But Nadeau says that wasn't true. 'I think obviously that their drone surveillance was bogus,' he told KGO-TV. 'We've lived in this house for 50 years and have maintained our roof in a very effective way.' He said he installed a new roof seven years ago and even spent $4,000 on an upgrade later on. He submitted invoices and photos to prove the roof had been replaced and upgraded. After his appeal, AAA reinstated his policy. Trending: Maximize saving for your retirement and cut down on taxes: . Marilyn Smith and her husband in Northern California were dropped for draining their pool to conserve water. They now use the empty pool as a hothouse to grow potted tomatoes and lettuce. 'I think I was in so much shock, I couldn't believe it,' she told KGO-TV. The AAA notice cited 'deferred maintenance' due to the empty pool. 'We decided well, we don't use it... that saves us on maintenance and then just the water,' she said. In a statement to KGO-TV, AAA parent company CSAA Insurance Group said it uses aerial imagery from satellites and fixed-wing aircraft to assess properties and determine whether they meet underwriting criteria. 'To continue offering industry-leading insurance coverage, we must periodically evaluate our exposure to risk,' the company said. , KUT in Austin, Texas, reported just last month that this drone surveillance policy continues. Tracy Gartenmann got an email from insurance company Travelers telling her she had two months to trim her trees or lose her coverage. Attached were two blurry photos taken from above her home. 'I thought it was a scam,' Gartenmann said. 'It wouldn't have crossed my mind that that would've been a mechanism or technique that a corporation could use.' Alaina Callahan, who lives outside Houston, was told she needed a new roof even though hers was just five years old and in good condition. She never got to see the photos. 'I had no recourse as a homeowner. None whatsoever,' she told KUT. Consumer advocacy group Texas Watch told KUT that the use of aerial images and AI removes the human touch and increases the risk of error. In one case, a homeowner lost coverage because the company used the wrong house image. KGO-TV reported that some homeowners have been able to find new coverage, often through insurers catering to military families. Others, like Nadeau in California, got reinstated after pushing back and sending documents about their roof being in good condition. Read Next: With Point, you can This Jeff Bezos-backed startup will allow you to .This article Got 'Clutter' In Your Backyard Or A Drained Pool? Insurance Companies Are Using Aerial Images To Decide If You'll Keep Your Coverage originally appeared on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
